C2 (Human) Polyclonal Goat Antiserum

$210.00

Purified Ig from goat antiserum raised against human C2 protein.

Brand	TECOmedical

SKU: A212C Category: Complement Polyclonal Antiserum

Description
Specifications

Description

General Description
Product is made from polyclonal antiserum from goats immunized with highly
purified human complement protein. Product is the purified IgG fraction. Goats are
maintained in FDA certified facilities.

Physical Characteristics & Structure
Antibodies present are primarily IgG.

Applications
Western Blots: Effective at dilutions 1/4,000 to 1/8,000 depending on conditions.
Note: Most effective against non-reduced antigen.
ELISA: Effective at dilutions 1/8,000 to 1/16,000 depending on conditions.
Radial immunodiffusion: 1/44 dilution (Vol/Vol) of anti-C2 IgG fraction in agarose gel results, after staining, in clear precipitin rings with
neat, 1:2 and 1:4 dilutions of NHS (3 mm wells, 20 µl sample). versus activated ½ diluted NHS assayed by immunodiffusion and staining of the precipitin band.
Immunodiffusion: Effective at 1/8 dilution against NHS or plasma.

Specifications

Sizes Available: 1.0 mL
Concentration: >20 mg/mL purified IgG concentration (not affinity purified).
Extinction Coeff. A280 nm = 1.35 at 1.0 mg/mL
Form: Frozen liquid, clear solution.
Buffer: Phosphate-buffered saline, pH 7.2
Activity: 1/8 dilution versus NHS assayed by immunodiffusion. 1/8,000 effective concentration in Western Blots 1/16,000 effective concentration in ELISA.
Preservative: 0.09 % sodium azide, filtered through 0.22 µm filter.
Storage: -20o C or below (long term), +4o C (short term, <30 days)
Source: Goats (Capra aegagrus hircus) immunized with highly purified human complement protein.
Specificity: Monospecific for human C2 in human plasma or serum.
Origin: Manufactured in the USA.

GSA MEDICAL portfolio offers a comprehensive workflow for your lab needs with wide range of tools.

As of 2020, GSA MEDICAL INC. started providing premier Manufacturing services to the diagnostic industry. GSA MEDICAL can effectively analyze the feasibility of reagents for use in rapid immunoassays. This process offers a quick glance as to the potential a reagent or concept may have and can result in saving considerable time and money for GSAMEDICAL’s clients.

We provide strong personal support, technical competence, and experience to ensure customer expectations will be met or exceeded.

Shop Products